Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Commercial
Financial
Financial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Financial
Karuna Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
Biospace News
-
November 21, 2019
Financial
Entera Bio Reports Third Quarter 2019 Financial Results and Provides Operating Update
Financial
Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering
Financial
Mallinckrodt plc Announces Early Results of Exchange Transactions
Financial
Mallinckrodt plc Announces Early Results of Exchange Transactions
Financial
BerGenBio ASA: Results for the Third Quarter 2019
Biospace News
-
November 19, 2019
0
Financial
Cerecor Reports Third Quarter 2019 Results
Biospace News
-
November 14, 2019
0
Financial
Correvio Reports Third Quarter 2019 Financial Results
Biospace News
-
November 14, 2019
0
Financial
Eton Pharmaceuticals Announces Third Quarter Financial Results and Highlights Business Progress
Biospace News
-
November 14, 2019
0
Financial
Osmotica Pharmaceuticals plc Reports Third Quarter 2019 Results
Biospace News
-
November 14, 2019
0
1
2
3
...
96
Page 1 of 96
- Advertisement -
MOST POPULAR
Eton Pharmaceuticals Announces Third Quarter Financial Results and Highlights Business Progress
November 14, 2019
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands...
March 11, 2019
Vericel Reports First Quarter 2019 Financial Results and Raises Full Year...
May 7, 2019
Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as...
November 20, 2019
Load more
HOT NEWS
Others
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical...
Approval
Marketing Authorisation for Xonvea in Ireland
Commercial
Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA (Omadacycline) with New ECCMID...
IND
Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as...
